Indian Pharma
-
{
- All
- News
- Videos
-
Russian Drone Strike Destroys Indian-Owned Pharma Unit In Ukraine, One Dead
The Kusum Group describes itself as a Ukrainian company with Indian roots and sells mostly generic medicines across several countries.
-
India's Pharma Opportunity: Expanding Global Reach In A Changing Healthcare Landscape
India's pharmaceutical industry is now at a critical juncture in its evolution.
-
India's Pharma Opportunity: Expanding Global Reach In A Changing Healthcare Landscape
India's pharmaceutical industry is now at a critical juncture in its evolution.
-
Weight Loss Injection For ₹900? Three Pharma Firms Launch Affordable Semaglutide, Check Prices
Indian pharmaceutical companies have launched affordable versions of semaglutide injections following a patent expiry, significantly lowering costs for diabetes and weight management treatment and improving access for millions of patients.
-
India's Drug Standards Gain Global Recognition, Rise From 123rd To 8th Spot: Union Health Minister
India has risen to 8th position globally from 123rd in the World Health Organizations (WHO) pharmacovigilance contributions, said Union Minister for Health and Family Welfare J. P. Nadda on Friday.
-
India's Drug Standards Gain Global Recognition, Rise From 123rd To 8th Spot: Union Health Minister
India has risen to 8th position globally from 123rd in the World Health Organizations (WHO) pharmacovigilance contributions, said Union Minister for Health and Family Welfare J. P. Nadda on Friday.
-
Indian Pharmaceutical Industry Transformed By GST Reforms And Research Development In 2025
With GST reforms and Research Development Incentive (RDI) Scheme, the year 2025 has been a crucial turning point for Indian pharma, said industry experts on Thursday.
-
Indian Pharmaceutical Industry Transformed By GST Reforms And Research Development In 2025
With GST reforms and Research Development Incentive (RDI) Scheme, the year 2025 has been a crucial turning point for Indian pharma, said industry experts on Thursday.
-
Trump Tariffs May Not Hurt Indian Companies, Says Morgan Stanley: THIS Pharma Stock An Exception
Morgan Stanley believes the impact could be limited, as far as the Indian market is concerned. However, companies like Sun Pharma could be at risk due to their speciality drug presence in the US.
-
Tariff Shock To Impact Indian Markets? Emkay's Manish Sonthalia Sees A Silver Lining
Sonthalia argues that the Indian currency has entered the undervalued territory and that any impact of the Trump tariffs has already been priced in, to an extent.
-
Why Trump's 100% Pharma Tariffs May Not Impact Indian Drugmakers Much
US President Donald Trump has said his administration will impose 100 per cent import tariffs on branded or patented pharmaceutical drugs from October 1, unless the pharma companies have or are building their manufacturing units in America.
-
Deals, Drugs, And Disruption: Glenmark, Lupin, IPCA Labs And Others Lead India's Pharma Opportunity Boom
The pharmaceutical sector has seen a flurry of new deals, partnerships, and drug launches this week, presenting potential significant growth opportunities in oncology, biosimilars, and diabetes care.
-
Russian Missile Strikes Indian Pharma Firm's Kyiv Warehouse: Ukraine
A Russian missile struck the warehouse of an Indian pharmaceutical company in Kyiv, Ukraine said today. The country's embassy in India alleged Russia "deliberately" targeted Indian businesses in Ukraine.
-
AI To Help Indian Pharma Industry To Pivot On Innovation, Reach 130 Billion In Size By 2030
Technological advancements like AI, machine learning and precision medicine are set to revolutionise drug discovery, manufacturing and patient care.
-
Pharma Industry To Grow By 9% To 11% In 2021-22: ICRA
ICRA has said that the pharmaceutical industry is estimated to grow at the rate of 9 per cent to 11 per cent in 2021-22 due to emerging markets
-
Russian Drone Strike Destroys Indian-Owned Pharma Unit In Ukraine, One Dead
The Kusum Group describes itself as a Ukrainian company with Indian roots and sells mostly generic medicines across several countries.
-
India's Pharma Opportunity: Expanding Global Reach In A Changing Healthcare Landscape
India's pharmaceutical industry is now at a critical juncture in its evolution.
-
India's Pharma Opportunity: Expanding Global Reach In A Changing Healthcare Landscape
India's pharmaceutical industry is now at a critical juncture in its evolution.
-
Weight Loss Injection For ₹900? Three Pharma Firms Launch Affordable Semaglutide, Check Prices
Indian pharmaceutical companies have launched affordable versions of semaglutide injections following a patent expiry, significantly lowering costs for diabetes and weight management treatment and improving access for millions of patients.
-
India's Drug Standards Gain Global Recognition, Rise From 123rd To 8th Spot: Union Health Minister
India has risen to 8th position globally from 123rd in the World Health Organizations (WHO) pharmacovigilance contributions, said Union Minister for Health and Family Welfare J. P. Nadda on Friday.
-
India's Drug Standards Gain Global Recognition, Rise From 123rd To 8th Spot: Union Health Minister
India has risen to 8th position globally from 123rd in the World Health Organizations (WHO) pharmacovigilance contributions, said Union Minister for Health and Family Welfare J. P. Nadda on Friday.
-
Indian Pharmaceutical Industry Transformed By GST Reforms And Research Development In 2025
With GST reforms and Research Development Incentive (RDI) Scheme, the year 2025 has been a crucial turning point for Indian pharma, said industry experts on Thursday.
-
Indian Pharmaceutical Industry Transformed By GST Reforms And Research Development In 2025
With GST reforms and Research Development Incentive (RDI) Scheme, the year 2025 has been a crucial turning point for Indian pharma, said industry experts on Thursday.
-
Trump Tariffs May Not Hurt Indian Companies, Says Morgan Stanley: THIS Pharma Stock An Exception
Morgan Stanley believes the impact could be limited, as far as the Indian market is concerned. However, companies like Sun Pharma could be at risk due to their speciality drug presence in the US.
-
Tariff Shock To Impact Indian Markets? Emkay's Manish Sonthalia Sees A Silver Lining
Sonthalia argues that the Indian currency has entered the undervalued territory and that any impact of the Trump tariffs has already been priced in, to an extent.
-
Why Trump's 100% Pharma Tariffs May Not Impact Indian Drugmakers Much
US President Donald Trump has said his administration will impose 100 per cent import tariffs on branded or patented pharmaceutical drugs from October 1, unless the pharma companies have or are building their manufacturing units in America.
-
Deals, Drugs, And Disruption: Glenmark, Lupin, IPCA Labs And Others Lead India's Pharma Opportunity Boom
The pharmaceutical sector has seen a flurry of new deals, partnerships, and drug launches this week, presenting potential significant growth opportunities in oncology, biosimilars, and diabetes care.
-
Russian Missile Strikes Indian Pharma Firm's Kyiv Warehouse: Ukraine
A Russian missile struck the warehouse of an Indian pharmaceutical company in Kyiv, Ukraine said today. The country's embassy in India alleged Russia "deliberately" targeted Indian businesses in Ukraine.
-
AI To Help Indian Pharma Industry To Pivot On Innovation, Reach 130 Billion In Size By 2030
Technological advancements like AI, machine learning and precision medicine are set to revolutionise drug discovery, manufacturing and patient care.
-
Pharma Industry To Grow By 9% To 11% In 2021-22: ICRA
ICRA has said that the pharmaceutical industry is estimated to grow at the rate of 9 per cent to 11 per cent in 2021-22 due to emerging markets
